Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin + 5-FU + FA in Advanced Cervical Cancer
NCT00782041Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Jan 2003
- Primary completion
- Aug 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in Cervical Cancer (CC), sponsored by Sanofi. Primary endpoint: Overall Response Rate. Started Jan 2003; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00782041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00782041.